Loading...
Header Logo
Keywords
Last Name
Institution

DAVID G MENTER

TitleAssistant Professor
InstitutionMD Anderson
DepartmentGI Medical Oncology
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Korphaisarn K, Morris V, Davis JS, Overman MJ, Fogelman DR, Kee BK, Dasari A, Raghav KPS, Shureiqi I, Trupti M, Wolff RA, Eng C, Menter DG, Hamilton S, Kopetz S. Signet ring cell colorectal cancer: genomic insights into a rare subpopulation of colorectal adenocarcinoma. Br J Cancer. 2019 Sep; 121(6):505-510. PMID: 31406299.
      View in: PubMed
    2. Batth IS, Mitra A, Rood S, Kopetz S, Menter D, Li S. CTC analysis: an update on technological progress. Transl Res. 2019 Jul 11. PMID: 31348892.
      View in: PubMed
    3. Willauer AN, Liu Y, Pereira AAL, Lam M, Morris JS, Raghav KPS, Morris VK, Menter D, Broaddus R, Meric-Bernstam F, Hayes-Jordan A, Huh W, Overman MJ, Kopetz S, Loree JM. Clinical and molecular characterization of early-onset colorectal cancer. Cancer. 2019 Jun 15; 125(12):2002-2010. PMID: 30854646.
      View in: PubMed
    4. Zacharias NM, Ornelas A, Lee J, Hu J, Davis JS, Uddin N, Pudakalakatti S, Menter DG, Karam JA, Wood CG, Hawk ET, Kopetz S, Vilar E, Bhattacharya PK, Millward SW. Real-Time Interrogation of Aspirin Reactivity, Biochemistry, and Biodistribution by Hyperpolarized Magnetic Resonance Spectroscopy. Angew Chem Int Ed Engl. 2019 Mar 22; 58(13):4179-4183. PMID: 30680862.
      View in: PubMed
    5. Menter DG, Davis JS, Broom BM, Overman MJ, Morris J, Kopetz S. Back to the Colorectal Cancer Consensus Molecular Subtype Future. Curr Gastroenterol Rep. 2019 Jan 30; 21(2):5. PMID: 30701321.
      View in: PubMed
    6. Varkaris A, Katsiampoura A, Davis JS, Shah N, Lam M, Frias RL, Ivan C, Shimizu M, Morris J, Menter D, Overman M, Tran H, Heymach J, Chun YS, Vauthey JN, Calin G, Kopetz S. Circulating inflammation signature predicts overall survival and relapse-free survival in metastatic colorectal cancer. Br J Cancer. 2019 Feb; 120(3):340-345. PMID: 30636774.
      View in: PubMed
    7. Kim SH, Roszik J, Cho SN, Ogata D, Milton DR, Peng W, Menter DG, Ekmekcioglu S, Grimm EA. The COX2 Effector Microsomal PGE2 Synthase 1 is a Regulator of Immunosuppression in Cutaneous Melanoma. Clin Cancer Res. 2019 Mar 01; 25(5):1650-1663. PMID: 30538110.
      View in: PubMed
    8. Adam L, San Lucas FA, Fowler R, Yu Y, Wu W, Liu Y, Wang H, Menter D, Tetzlaff MT, Ensor J, Manyam G, Arold ST, Huff C, Kopetz S, Scheet P, Overman MJ. DNA Sequencing of Small Bowel Adenocarcinomas Identifies Targetable Recurrent Mutations in the ERBB2 Signaling Pathway. Clin Cancer Res. 2019 Jan 15; 25(2):641-651. PMID: 30352910.
      View in: PubMed
    9. Kanikarla-Marie P, Kopetz S, Hawk ET, Millward SW, Sood AK, Gresele P, Overman M, Honn K, Menter DG. Bioactive lipid metabolism in platelet "first responder" and cancer biology. Cancer Metastasis Rev. 2018 09; 37(2-3):439-454. PMID: 30112590.
      View in: PubMed
    10. Kanikarla-Marie P, Lam M, Sorokin AV, Overman MJ, Kopetz S, Menter DG. Platelet Metabolism and Other Targeted Drugs; Potential Impact on Immunotherapy. Front Oncol. 2018; 8:107. PMID: 29732316.
      View in: PubMed
    11. Haemmerle M, Stone RL, Menter DG, Afshar-Kharghan V, Sood AK. The Platelet Lifeline to Cancer: Challenges and Opportunities. Cancer Cell. 2018 06 11; 33(6):965-983. PMID: 29657130.
      View in: PubMed
    12. Korphaisarn K, Chou CK, Xia WY, Clarke CN, Katkhuda R, Davis JS, Raghav KP, Liao HW, Wu JY, Menter DG, Maru DM, Hung MC, Kopetz S. Arginine methylation of EGFR: a new biomarker for predicting resistance to anti-EGFR treatment. Am J Cancer Res. 2017; 7(12):2587-2599. PMID: 29312811.
      View in: PubMed
    13. Loree JM, Pereira AAL, Lam M, Willauer AN, Raghav K, Dasari A, Morris VK, Advani S, Menter DG, Eng C, Shaw K, Broaddus R, Routbort MJ, Liu Y, Morris JS, Luthra R, Meric-Bernstam F, Overman MJ, Maru D, Kopetz S. Classifying Colorectal Cancer by Tumor Location Rather than Sidedness Highlights a Continuum in Mutation Profiles and Consensus Molecular Subtypes. Clin Cancer Res. 2018 03 01; 24(5):1062-1072. PMID: 29180604.
      View in: PubMed
    14. Menter DG, Kanikarla-Marie P, Lam M, Davis JS, Kopetz S. Platelet microparticles: small payloads with profound effects on tumor growth. Noncoding RNA Investig. 2017 Nov; 1. PMID: 31218277.
      View in: PubMed
    15. Clarke CN, Lee MS, Wei W, Manyam G, Jiang ZQ, Lu Y, Morris J, Broom B, Menter D, Vilar-Sanchez E, Raghav K, Eng C, Chang GJ, Simon I, Bernards R, Overman M, Mills GB, Maru D, Kopetz S. Proteomic Features of Colorectal Cancer Identify Tumor Subtypes Independent of Oncogenic Mutations and Independently Predict Relapse-Free Survival. Ann Surg Oncol. 2017 Dec; 24(13):4051-4058. PMID: 28936799.
      View in: PubMed
    16. Korphaisarn K, Morris VK, Overman MJ, Fogelman DR, Kee BK, Raghav KPS, Manuel S, Shureiqi I, Wolff RA, Eng C, Menter D, Hamilton SR, Kopetz S, Dasari A. FBXW7 missense mutation: a novel negative prognostic factor in metastatic colorectal adenocarcinoma. Oncotarget. 2017 Jun 13; 8(24):39268-39279. PMID: 28424412.
      View in: PubMed
    17. Lin SH, Raju GS, Huff C, Ye Y, Gu J, Chen JS, Hildebrandt MAT, Liang H, Menter DG, Morris J, Hawk E, Stroehlein JR, Futreal A, Kopetz S, Mishra L, Wu X. The somatic mutation landscape of premalignant colorectal adenoma. Gut. 2018 07; 67(7):1299-1305. PMID: 28607096.
      View in: PubMed
    18. Kanikarla-Marie P, Lam M, Menter DG, Kopetz S. Platelets, circulating tumor cells, and the circulome. Cancer Metastasis Rev. 2017 06; 36(2):235-248. PMID: 28667367.
      View in: PubMed
    19. Menter D. Preface. Cancer Metastasis Rev. 2017 06; 36(2):193-194. PMID: 28681239.
      View in: PubMed
    20. Lam M, Roszik J, Kanikarla-Marie P, Davis JS, Morris J, Kopetz S, Menter DG. The potential role of platelets in the consensus molecular subtypes of colorectal cancer. Cancer Metastasis Rev. 2017 06; 36(2):273-288. PMID: 28681242.
      View in: PubMed
    21. Menter DG, Kopetz S, Hawk E, Sood AK, Loree JM, Gresele P, Honn KV. Platelet "first responders" in wound response, cancer, and metastasis. Cancer Metastasis Rev. 2017 06; 36(2):199-213. PMID: 28730545.
      View in: PubMed
    22. Ornelas A, Zacharias-Millward N, Menter DG, Davis JS, Lichtenberger L, Hawke D, Hawk E, Vilar E, Bhattacharya P, Millward S. Beyond COX-1: the effects of aspirin on platelet biology and potential mechanisms of chemoprevention. Cancer Metastasis Rev. 2017 06; 36(2):289-303. PMID: 28762014.
      View in: PubMed
    23. Rigoutsos I, Lee SK, Nam SY, Anfossi S, Pasculli B, Pichler M, Jing Y, Rodriguez-Aguayo C, Telonis AG, Rossi S, Ivan C, Catela Ivkovic T, Fabris L, Clark PM, Ling H, Shimizu M, Redis RS, Shah MY, Zhang X, Okugawa Y, Jung EJ, Tsirigos A, Huang L, Ferdin J, Gafà R, Spizzo R, Nicoloso MS, Paranjape AN, Shariati M, Tiron A, Yeh JJ, Teruel-Montoya R, Xiao L, Melo SA, Menter D, Jiang ZQ, Flores ER, Negrini M, Goel A, Bar-Eli M, Mani SA, Liu CG, Lopez-Berestein G, Berindan-Neagoe I, Esteller M, Kopetz S, Lanza G, Calin GA. N-BLR, a primate-specific non-coding transcript leads to colorectal cancer invasion and migration. Genome Biol. 2017 05 24; 18(1):98. PMID: 28535802.
      View in: PubMed
    24. Katsiampoura A, Raghav K, Jiang ZQ, Menter DG, Varkaris A, Morelli MP, Manuel S, Wu J, Sorokin AV, Rizi BS, Bristow C, Tian F, Airhart S, Cheng M, Broom BM, Morris J, Overman MJ, Powis G, Kopetz S. Modeling of Patient-Derived Xenografts in Colorectal Cancer. Mol Cancer Ther. 2017 07; 16(7):1435-1442. PMID: 28468778.
      View in: PubMed
    25. Wagner MJ, Ravi V, Menter DG, Sood AK. Endothelial cell malignancies: new insights from the laboratory and clinic. NPJ Precis Oncol. 2017; 1(1):11. PMID: 29872699.
      View in: PubMed
    26. Parseghian CM, Parikh NU, Wu JY, Jiang ZQ, Henderson L, Tian F, Pastor B, Ychou M, Raghav K, Dasari A, Fogelman DR, Katsiampoura AD, Menter DG, Wolff RA, Eng C, Overman MJ, Thierry AR, Gallick GE, Kopetz S. Dual Inhibition of EGFR and c-Src by Cetuximab and Dasatinib Combined with FOLFOX Chemotherapy in Patients with Metastatic Colorectal Cancer. Clin Cancer Res. 2017 Aug 01; 23(15):4146-4154. PMID: 28280091.
      View in: PubMed
    27. Lee MS, Menter DG, Kopetz S. Right Versus Left Colon Cancer Biology: Integrating the Consensus Molecular Subtypes. J Natl Compr Canc Netw. 2017 03; 15(3):411-419. PMID: 28275039.
      View in: PubMed
    28. Raghav K, Morris V, Tang C, Morelli P, Amin HM, Chen K, Manyam GC, Broom B, Overman MJ, Shaw K, Meric-Bernstam F, Maru D, Menter D, Ellis LM, Eng C, Hong D, Kopetz S. MET amplification in metastatic colorectal cancer: an acquired response to EGFR inhibition, not a de novo phenomenon. Oncotarget. 2016 08 23; 7(34):54627-54631. PMID: 27421137.
      View in: PubMed
    29. Whiting N, Hu J, Zacharias NM, Lokesh GL, Volk DE, Menter DG, Rupaimoole R, Previs R, Sood AK, Bhattacharya P. Developing hyperpolarized silicon particles for in vivo MRI targeting of ovarian cancer. J Med Imaging (Bellingham). 2016 Jul; 3(3):036001. PMID: 27547777.
      View in: PubMed
    30. Kim SH, Hashimoto Y, Cho SN, Roszik J, Milton DR, Dal F, Kim SF, Menter DG, Yang P, Ekmekcioglu S, Grimm EA. Microsomal PGE2 synthase-1 regulates melanoma cell survival and associates with melanoma disease progression. Pigment Cell Melanoma Res. 2016 May; 29(3):297-308. PMID: 26801201.
      View in: PubMed
    31. Umar A, Steele VE, Menter DG, Hawk ET. Mechanisms of nonsteroidal anti-inflammatory drugs in cancer prevention. Semin Oncol. 2016 Feb; 43(1):65-77. PMID: 26970125.
      View in: PubMed
    32. Fang L, Lu W, Choi HH, Yeung SC, Tung JY, Hsiao CD, Fuentes-Mattei E, Menter D, Chen C, Wang L, Wang J, Lee MH. ERK2-Dependent Phosphorylation of CSN6 Is Critical in Colorectal Cancer Development. Cancer Cell. 2015 Aug 10; 28(2):183-97. PMID: 26267535.
      View in: PubMed
    33. Whiting N, Hu J, Shah JV, Cassidy MC, Cressman E, Millward NZ, Menter DG, Marcus CM, Bhattacharya PK. Real-Time MRI-Guided Catheter Tracking Using Hyperpolarized Silicon Particles. Sci Rep. 2015 Aug 04; 5:12842. PMID: 26239953.
      View in: PubMed
    34. Chen ZY, Raghav K, Lieu CH, Jiang ZQ, Eng C, Vauthey JN, Chang GJ, Qiao W, Morris J, Hong D, Hoff P, Tran H, Menter DG, Heymach J, Overman M, Kopetz S. Cytokine profile and prognostic significance of high neutrophil-lymphocyte ratio in colorectal cancer. Br J Cancer. 2015 Mar 17; 112(6):1088-97. PMID: 25688736.
      View in: PubMed
    35. Menter DG, Patterson SL, Logsdon CD, Kopetz S, Sood AK, Hawk ET. Convergence of nanotechnology and cancer prevention: are we there yet? Cancer Prev Res (Phila). 2014 Oct; 7(10):973-92. PMID: 25060262.
      View in: PubMed
    36. Menter DG, Tucker SC, Kopetz S, Sood AK, Crissman JD, Honn KV. Platelets and cancer: a casual or causal relationship: revisited. Cancer Metastasis Rev. 2014 Mar; 33(1):231-69. PMID: 24696047.
      View in: PubMed
    37. Charo C, Holla V, Arumugam T, Hwang R, Yang P, Dubois RN, Menter DG, Logsdon CD, Ramachandran V. Prostaglandin E2 regulates pancreatic stellate cell activity via the EP4 receptor. Pancreas. 2013 Apr; 42(3):467-74. PMID: 23090667.
      View in: PubMed
    38. Yang P, Cartwright C, Efuet E, Hamilton SR, Wistuba II, Menter D, Addington C, Shureiqi I, Newman RA. Cellular location and expression of Na+, K+ -ATPase a subunits affect the anti-proliferative activity of oleandrin. Mol Carcinog. 2014 Apr; 53(4):253-63. PMID: 23073998.
      View in: PubMed
    39. Menter DG, Dubois RN. Prostaglandins in cancer cell adhesion, migration, and invasion. Int J Cell Biol. 2012; 2012:723419. PMID: 22505934.
      View in: PubMed
    40. Menter DG, Ramsauer VP, Harirforoosh S, Chakraborty K, Yang P, Hsi L, Newman RA, Krishnan K. Differential effects of pravastatin and simvastatin on the growth of tumor cells from different organ sites. PLoS One. 2011; 6(12):e28813. PMID: 22216116.
      View in: PubMed
    41. Holla VR, Wu H, Shi Q, Menter DG, DuBois RN. Nuclear orphan receptor NR4A2 modulates fatty acid oxidation pathways in colorectal cancer. J Biol Chem. 2011 Aug 26; 286(34):30003-9. PMID: 21757690.
      View in: PubMed
    42. Campbell SE, Rudder B, Phillips RB, Whaley SG, Stimmel JB, Leesnitzer LM, Lightner J, Dessus-Babus S, Duffourc M, Stone WL, Menter DG, Newman RA, Yang P, Aggarwal BB, Krishnan K. ?-Tocotrienol induces growth arrest through a novel pathway with TGFß2 in prostate cancer. Free Radic Biol Med. 2011 May 15; 50(10):1344-54. PMID: 21335085.
      View in: PubMed
    43. Kim SH, Xia D, Kim SW, Holla V, Menter DG, Dubois RN. Human enhancer of filamentation 1 Is a mediator of hypoxia-inducible factor-1alpha-mediated migration in colorectal carcinoma cells. Cancer Res. 2010 May 15; 70(10):4054-63. PMID: 20442290.
      View in: PubMed
    44. Menter DG, Schilsky RL, DuBois RN. Cyclooxygenase-2 and cancer treatment: understanding the risk should be worth the reward. Clin Cancer Res. 2010 Mar 01; 16(5):1384-90. PMID: 20179228.
      View in: PubMed
    45. Xia D, Holla VR, Wang D, Menter DG, DuBois RN. HEF1 is a crucial mediator of the proliferative effects of prostaglandin E(2) on colon cancer cells. Cancer Res. 2010 Jan 15; 70(2):824-31. PMID: 20068165.
      View in: PubMed
    46. Yang P, Menter DG, Cartwright C, Chan D, Dixon S, Suraokar M, Mendoza G, Llansa N, Newman RA. Oleandrin-mediated inhibition of human tumor cell proliferation: importance of Na,K-ATPase alpha subunits as drug targets. Mol Cancer Ther. 2009 Aug; 8(8):2319-28. PMID: 19671733.
      View in: PubMed
    47. Shin S, Asano T, Yao Y, Zhang R, Claret FX, Korc M, Sabapathy K, Menter DG, Abbruzzese JL, Reddy SAG. Activator protein-1 has an essential role in pancreatic cancer cells and is regulated by a novel Akt-mediated mechanism. Mol Cancer Res. 2009 May; 7(5):745-754. PMID: 19435822.
      View in: PubMed
    48. Tsavachidou D, McDonnell TJ, Wen S, Wang X, Vakar-Lopez F, Pisters LL, Pettaway CA, Wood CG, Do KA, Thall PF, Stephens C, Efstathiou E, Taylor R, Menter DG, Troncoso P, Lippman SM, Logothetis CJ, Kim J. Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancer. J Natl Cancer Inst. 2009 Mar 04; 101(5):306-20. PMID: 19244175.
      View in: PubMed
    49. Jin Q, Menter DG, Mao L, Hong WK, Lee HY. Survivin expression in normal human bronchial epithelial cells: an early and critical step in tumorigenesis induced by tobacco exposure. Carcinogenesis. 2008 Aug; 29(8):1614-22. PMID: 18635526.
      View in: PubMed
    50. Gutierrez-Barrera AM, Menter DG, Abbruzzese JL, Reddy SA. Establishment of three-dimensional cultures of human pancreatic duct epithelial cells. Biochem Biophys Res Commun. 2007 Jul 06; 358(3):698-703. PMID: 17512909.
      View in: PubMed
    51. Subbarayan V, Krieg P, Hsi LC, Kim J, Yang P, Sabichi AL, Llansa N, Mendoza G, Logothetis CJ, Newman RA, Lippman SM, Menter DG. 15-Lipoxygenase-2 gene regulation by its product 15-(S)-hydroxyeicosatetraenoic acid through a negative feedback mechanism that involves peroxisome proliferator-activated receptor gamma. Oncogene. 2006 Sep 28; 25(44):6015-25. PMID: 16682954.
      View in: PubMed
    52. Sabichi AL, Lee JJ, Taylor RJ, Thompson IM, Miles BJ, Tangen CM, Minasian LM, Pisters LL, Caton JR, Basler JW, Lerner SP, Menter DG, Marshall JR, Crawford ED, Lippman SM. Selenium accumulation in prostate tissue during a randomized, controlled short-term trial of l-selenomethionine: a Southwest Oncology Group Study. Clin Cancer Res. 2006 Apr 01; 12(7 Pt 1):2178-84. PMID: 16609032.
      View in: PubMed
    53. Kim J, Yang P, Suraokar M, Sabichi AL, Llansa ND, Mendoza G, Subbarayan V, Logothetis CJ, Newman RA, Lippman SM, Menter DG. Suppression of prostate tumor cell growth by stromal cell prostaglandin D synthase-derived products. Cancer Res. 2005 Jul 15; 65(14):6189-98. PMID: 16024620.
      View in: PubMed
    54. Subbarayan V, Xu XC, Kim J, Yang P, Hoque A, Sabichi AL, Llansa N, Mendoza G, Logothetis CJ, Newman RA, Lippman SM, Menter DG. Inverse relationship between 15-lipoxygenase-2 and PPAR-gamma gene expression in normal epithelia compared with tumor epithelia. Neoplasia. 2005 Mar; 7(3):280-93. PMID: 15799828.
      View in: PubMed
    55. Subbarayan V, Sabichi AL, Kim J, Llansa N, Logothetis CJ, Lippman SM, Menter DG. Differential peroxisome proliferator-activated receptor-gamma isoform expression and agonist effects in normal and malignant prostate cells. Cancer Epidemiol Biomarkers Prev. 2004 Nov; 13(11 Pt 1):1710-6. PMID: 15533897.
      View in: PubMed
    56. Sabichi AL, Subbarayan V, Llansa N, Lippman SM, Menter DG. Peroxisome proliferator-activated receptor-gamma suppresses cyclooxygenase-2 expression in human prostate cells. Cancer Epidemiol Biomarkers Prev. 2004 Nov; 13(11 Pt 1):1704-9. PMID: 15533896.
      View in: PubMed
    57. Yang P, Chan D, Felix E, Cartwright C, Menter DG, Madden T, Klein RD, Fischer SM, Newman RA. Formation and antiproliferative effect of prostaglandin E(3) from eicosapentaenoic acid in human lung cancer cells. J Lipid Res. 2004 Jun; 45(6):1030-9. PMID: 14993240.
      View in: PubMed
    58. Salas TR, Kim J, Vakar-Lopez F, Sabichi AL, Troncoso P, Jenster G, Kikuchi A, Chen SY, Shemshedini L, Suraokar M, Logothetis CJ, DiGiovanni J, Lippman SM, Menter DG. Glycogen synthase kinase-3 beta is involved in the phosphorylation and suppression of androgen receptor activity. J Biol Chem. 2004 Apr 30; 279(18):19191-200. PMID: 14985354.
      View in: PubMed
    59. Salas TR, Reddy SA, Clifford JL, Davis RJ, Kikuchi A, Lippman SM, Menter DG. Alleviating the suppression of glycogen synthase kinase-3beta by Akt leads to the phosphorylation of cAMP-response element-binding protein and its transactivation in intact cell nuclei. J Biol Chem. 2003 Oct 17; 278(42):41338-46. PMID: 12900420.
      View in: PubMed
    60. Xu XC, Shappell SB, Liang Z, Song S, Menter D, Subbarayan V, Iyengar S, Tang DG, Lippman SM. Reduced 15S-lipoxygenase-2 expression in esophageal cancer specimens and cells and upregulation in vitro by the cyclooxygenase-2 inhibitor, NS398. Neoplasia. 2003 Mar-Apr; 5(2):121-7. PMID: 12659684.
      View in: PubMed
    61. Menter DG. Cyclooxygenase 2 selective inhibitors in cancer treatment and prevention. Expert Opin Investig Drugs. 2002 Dec; 11(12):1749-64. PMID: 12457435.
      View in: PubMed
    62. Hoque A, Sneige N, Sahin AA, Menter DG, Bacus JW, Hortobagyi GN, Lippman SM. Her-2/neu gene amplification in ductal carcinoma in situ of the breast. Cancer Epidemiol Biomarkers Prev. 2002 Jun; 11(6):587-90. PMID: 12050101.
      View in: PubMed
    63. Menter DG, Hoque A, Motiwala N, Sahin AA, Sneige N, Lieberman R, Lippman SM. Computerized image analysis of Ki-67 in ductal breast carcinoma in situ. Anal Quant Cytol Histol. 2001 Jun; 23(3):218-28. PMID: 11444192.
      View in: PubMed
    64. Subbarayan V, Sabichi AL, Llansa N, Lippman SM, Menter DG. Differential expression of cyclooxygenase-2 and its regulation by tumor necrosis factor-alpha in normal and malignant prostate cells. Cancer Res. 2001 Mar 15; 61(6):2720-6. PMID: 11289153.
      View in: PubMed
    65. Hoque A, Menter DG, Sahin AA, Sneige N, Lippman SM. No increased Ki67 expression in ductal carcinoma in situ associated with invasive breast cancer. Cancer Epidemiol Biomarkers Prev. 2001 Feb; 10(2):153-4. PMID: 11219775.
      View in: PubMed
    66. Menter DG, Sabichi AL, Lippman SM. Selenium effects on prostate cell growth. Cancer Epidemiol Biomarkers Prev. 2000 Nov; 9(11):1171-82. PMID: 11097224.
      View in: PubMed
    67. Clifford JL, Menter DG, Yang X, Walch E, Zou C, Clayman GL, Schaefer TS, El-Naggar AK, Lotan R, Lippman SM. Expression of protein mediators of type I interferon signaling in human squamous cell carcinoma of the skin. Cancer Epidemiol Biomarkers Prev. 2000 Sep; 9(9):993-7. PMID: 11008921.
      View in: PubMed
    68. Wu H, Lotan R, Menter D, Lippman SM, Xu XC. Expression of E-cadherin is associated with squamous differentiation in squamous cell carcinomas. Anticancer Res. 2000 May-Jun; 20(3A):1385-90. PMID: 10928048.
      View in: PubMed
    69. Schaefer LK, Menter DG, Schaefer TS. Activation of stat3 and stat1 DNA binding and transcriptional activity in human brain tumour cell lines by gp130 cytokines. Cell Signal. 2000 Mar; 12(3):143-51. PMID: 10704821.
      View in: PubMed
    70. Papadimitriou MN, McIntire LV, Menter DG. Effect of cyclooxygenase inhibitors in the adhesion of tumor cells to endothelial cells. Crit Rev Biomed Eng. 2000; 28(1-2):193-4. PMID: 10999385.
      View in: PubMed
    71. Clifford JL, Menter DG, Wang M, Lotan R, Lippman SM. Retinoid receptor-dependent and -independent effects of N-(4-hydroxyphenyl)retinamide in F9 embryonal carcinoma cells. Cancer Res. 1999 Jan 01; 59(1):14-8. PMID: 9892176.
      View in: PubMed
    72. Papadimitriou MN, Menter DG, Konstantopoulos K, Nicolson GL, McIntire LV. Integrin alpha4beta1/VCAM-1 pathway mediates primary adhesion of RAW117 lymphoma cells to hepatic sinusoidal endothelial cells under flow. Clin Exp Metastasis. 1999; 17(8):669-76. PMID: 10919712.
      View in: PubMed
    73. Herrmann JL, Menter DG, Beham A, von Eschenbach A, McDonnell TJ. Regulation of lipid signaling pathways for cell survival and apoptosis by bcl-2 in prostate carcinoma cells. Exp Cell Res. 1997 Aug 01; 234(2):442-51. PMID: 9260915.
      View in: PubMed
    74. Yun Z, Smith TW, Menter DG, McIntire LV, Nicolson GL. Differential adhesion of metastatic RAW117 large-cell lymphoma cells under static or hydrodynamic conditions: role of integrin alpha(v) beta3. Clin Exp Metastasis. 1997 Jan; 15(1):3-11. PMID: 9009100.
      View in: PubMed
    75. Smith TW, Menter DG, Nicholson GL, McIntire LV. Regulation of melanoma cell adhesion stabilization to fibronectin. Melanoma Res. 1996 Oct; 6(5):351-62. PMID: 8908595.
      View in: PubMed
    76. Yun Z, Menter DG, Nicolson GL. Involvement of integrin alphavbeta3 in cell adhesion, motility, and liver metastasis of murine RAW117 large cell lymphoma. Cancer Res. 1996 Jul 01; 56(13):3103-11. PMID: 8674068.
      View in: PubMed
    77. Smith TW, Yun Z, Menter DG, McIntire LV, Nicolson GL. Computerized analysis of tumor cell interactions with extracellular matrix proteins, peptides, and endothelial cells under laminar flow. Biotechnol Bioeng. 1996 Jun 05; 50(5):598-607. PMID: 18627023.
      View in: PubMed
    78. Nicolson GL, Menter DG, Herrmann JL, Yun Z, Cavanaugh P, Marchetti D. Brain metastasis: role of trophic, autocrine, and paracrine factors in tumor invasion and colonization of the central nervous system. Curr Top Microbiol Immunol. 1996; 213 ( Pt 2):89-115. PMID: 9053298.
      View in: PubMed
    79. Nicolson GL, Menter DG. Trophic factors and central nervous system metastasis. Cancer Metastasis Rev. 1995 Dec; 14(4):303-21. PMID: 8821092.
      View in: PubMed
    80. Menter DG, Fitzgerald L, Patton JT, McIntire LV, Nicolson GL. Human melanoma integrins contribute to arrest and stabilization potential while flowing over extracellular matrix. Immunol Cell Biol. 1995 Dec; 73(6):575-83. PMID: 8713481.
      View in: PubMed
    81. Menter DG, Herrmann JL, Nicolson GL. The role of trophic factors and autocrine/paracrine growth factors in brain metastasis. Clin Exp Metastasis. 1995 Mar; 13(2):67-88. PMID: 7882617.
      View in: PubMed
    82. Nicolson GL, Menter DG, Herrmann J, Cavanaugh P, Jia L, Hamada J, Yun Z, Nakajima M, Marchetti D. Tumor metastasis to brain: role of endothelial cells, neurotrophins, and paracrine growth factors. Crit Rev Oncog. 1994; 5(5):451-71. PMID: 8519808.
      View in: PubMed
    83. Nicolson GL, Nakajima M, Herrmann JL, Menter DG, Cavanaugh PG, Park JS, Marchetti D. Malignant melanoma metastasis to brain: role of degradative enzymes and responses to paracrine growth factors. J Neurooncol. 1994; 18(2):139-49. PMID: 7964976.
      View in: PubMed
    84. Menter DG, Herrmann JL, Marchetti D, Nicolson GL. Involvement of neurotrophins and growth factors in brain metastasis formation. Invasion Metastasis. 1994-1995; 14(1-6):372-84. PMID: 7657530.
      View in: PubMed
    85. Herrmann JL, Menter DG, Hamada J, Marchetti D, Nakajima M, Nicolson GL. Mediation of NGF-stimulated extracellular matrix invasion by the human melanoma low-affinity p75 neurotrophin receptor: melanoma p75 functions independently of trkA. Mol Biol Cell. 1993 Nov; 4(11):1205-16. PMID: 8305739.
      View in: PubMed
    86. Marchetti D, Menter D, Jin L, Nakajima M, Nicolson GL. Nerve growth factor effects on human and mouse melanoma cell invasion and heparanase production. Int J Cancer. 1993 Oct 21; 55(4):692-9. PMID: 8407001.
      View in: PubMed
    87. Patton JT, Menter DG, Benson DM, Nicolson GL, McIntire LV. Computerized analysis of tumor cells flowing in a parallel plate chamber to determine their adhesion stabilization lag time. Cell Motil Cytoskeleton. 1993; 26(1):88-98. PMID: 8106174.
      View in: PubMed
    88. Menter DG, Patton JT, Updyke TV, Kerbel RS, Maamer M, McIntire LV, Nicolson GL. Transglutaminase stabilizes melanoma adhesion under laminar flow. Cell Biophys. 1991 Apr; 18(2):123-43. PMID: 1726525.
      View in: PubMed
    89. Irimura T, McIsaac AM, Carlson DA, Yagita M, Grimm EA, Menter DG, Ota DM, Clary KR. Soluble factor in normal tissues that stimulates high-molecular-weight sialoglycoprotein production by human colon carcinoma cells. Cancer Res. 1990 Jun 01; 50(11):3331-8. PMID: 2334927.
      View in: PubMed
    90. Crissman JD, Hatfield JS, Menter DG, Sloane B, Honn KV. Morphological study of the interaction of intravascular tumor cells with endothelial cells and subendothelial matrix. Cancer Res. 1988 Jul 15; 48(14):4065-72. PMID: 3383198.
      View in: PubMed
    91. Menter DG, Steinert BW, Sloane BF, Gundlach N, O'Gara CY, Marnett LJ, Diglio C, Walz D, Taylor JD, Honn KV. Role of platelet membrane in enhancement of tumor cell adhesion to endothelial cell extracellular matrix. Cancer Res. 1987 Dec 15; 47(24 Pt 1):6751-62. PMID: 2824041.
      View in: PubMed
    92. Menter DG, Sloane BF, Steinert BW, Onoda J, Craig R, Harkins C, Taylor JD, Honn KV. Platelet enhancement of tumor cell adhesion to subendothelial matrix: role of platelet cytoskeleton and platelet membrane. J Natl Cancer Inst. 1987 Nov; 79(5):1077-90. PMID: 3479634.
      View in: PubMed
    93. Menter DG, Steinert BW, Sloane BF, Taylor JD, Honn KV. A new in vitro model for investigation of tumor cell-platelet-endothelial cell interactions and concomitant eicosanoid biosynthesis. Cancer Res. 1987 May 01; 47(9):2425-32. PMID: 3552214.
      View in: PubMed
    94. Menter DG, Onoda JM, Moilanen D, Sloane BF, Taylor JD, Honn KV. Inhibition by prostacyclin of the tumor cell-induced platelet release reaction and platelet aggregation. J Natl Cancer Inst. 1987 May; 78(5):961-9. PMID: 3553692.
      View in: PubMed
    95. Honn KV, Menter DG, Onoda JM, Steinert BW, Diglio CA, Taylor JD, Sloane BF. Tumor cell-platelet-endothelial cell interactions and prostaglandin metabolism. Adv Prostaglandin Thromboxane Leukot Res. 1987; 17B:981-5. PMID: 2960216.
      View in: PubMed
    96. Menter DG, Harkins C, Onoda J, Riorden W, Sloane BF, Taylor JD, Honn KV. Inhibition of tumor cell induced platelet aggregation by prostacyclin and carbacyclin: an ultrastructural study. Invasion Metastasis. 1987; 7(2):109-28. PMID: 3294727.
      View in: PubMed
    97. Menter DG, Hatfield JS, Harkins C, Sloane BF, Taylor JD, Crissman JD, Honn KV. Tumor cell-platelet interactions in vitro and their relationship to in vivo arrest of hematogenously circulating tumor cells. Clin Exp Metastasis. 1987 Jan-Mar; 5(1):65-78. PMID: 3829498.
      View in: PubMed
    98. Honn KV, Onoda JM, Menter DG, Cavanaugh PG, Taylor JD, Crissman JD, Ryan RE, Sloane BF. Possible strategies for antimetastastic therapy. Prog Clin Biol Res. 1986; 212:217-49. PMID: 3520578.
      View in: PubMed
    99. Menter DG, Onoda JM, Taylor JD, Honn KV. Effects of prostacyclin on tumor cell-induced platelet aggregation. Cancer Res. 1984 Feb; 44(2):450-6. PMID: 6362850.
      View in: PubMed
    100. Honn KV, Menter D, Cavanaugh PG, Neagos G, Moilanen D, Taylor JD, Sloane BF. A review of prostaglandins and the treatment of tumor metastasis. Acta Clin Belg. 1983; 38(1):53-67. PMID: 6405568.
      View in: PubMed
    101. Honn KV, Menter DG, Onoda JM, Taylor JD, Sloane BF. Role of prostacyclin as a natural deterrent to hematogenous tumor metastasis. Symp Fundam Cancer Res. 1983; 36:361-88. PMID: 6382514.
      View in: PubMed
    102. Menter DG, Obika M, Tchen TT, Taylor JD. Leucophores and iridophores of Fundulus heteroclitus: Biophysical and ultrastructural properties. J Morphol. 1979 Apr; 160(1):103-119. PMID: 30200688.
      View in: PubMed
    103. Obika M, Menter DG, Tchen TT, Taylor JD. Actin microfilaments in melanophores of Fundulus heteroclitus. Their possible involvement in melanosome migration. Cell Tissue Res. 1978 Oct 30; 193(3):387-97. PMID: 569547.
      View in: PubMed
    104. Obika M, Turner WA, Negishi S, Menter DG, Tchen TT, Taylor JD. The effects of lumicolchicine, colchicine and vinblastine on pigment migration in fish chromatophores. J Exp Zool. 1978 Jul; 205(1):95-110. PMID: 670923.
      View in: PubMed
    105. Effect of cyclooxygenase inhibitors in the adhesion of tumor cells to endothelial cells. Critical Reviews in Biomedical Engineering. 26:332-333.
    106. Arachidonic acid metabolism as a target for antimetastatic agents. Cancer Bulletin. 36:200-204.
    107. Leucophores and iridophores of Fundulus heteroclitus. Journal of Morphology. 160:103-120.
    108. Effects of transglutaminase inhibitors on tumor cell adhesion, spreading and detachment under defined wall shear stress. Annals of Biomedical Engineering. 19:592.
    109. Adjuvant Approaches for Preventing Brain Metastases. 445-460.
    110. MET amplification in metastatic colorectal cancer. Oncotarget. 7:54627-54631.
    111. Microsomal PGE2 synthase-1 regulates melanoma cell survival and associates with melanoma disease progression. Pigment Cell and Melanoma Research.
    112. Real-Time MRI-Guided Catheter Tracking Using Hyperpolarized Silicon Particles. Scientific Reports. 5.
    113. Neurotrophism. Cancer Bulletin. 47:131-139.
    114. Platelet enhanced tumor cell adhesion (PETCA) may depend on platelet dynamics during activation.
    115. Developing hyperpolarized silicon particles for in vivo MRI targeting of ovarian cancer. Journal of Medical Imaging. 3.
    116. Tumor cell-substrate stabilization mediated by integrins. 147-152.
    MENTER's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description